▶ 調査レポート

サウジアラビアの動物用医薬品市場2021年ー2031年:製品別(薬剤、ワクチン、薬用飼料添加物)、動物種類別、投与経路別、流通チャネル別

• 英文タイトル:Veterinary Therapeutics Market (Product: Drug, Vaccines, and Medicated Feed Additives; Animal Type: Companion Animals and Livestock Animals; Route of Administration: Oral, Parenteral, and Others; and Distribution Channel: Veterinary Hospitals & Clinics, Pharmacies & Drug Stores, and Others) - Saudi Arabia Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Transparency Market Researchが調査・発行した産業分析レポートです。サウジアラビアの動物用医薬品市場2021年ー2031年:製品別(薬剤、ワクチン、薬用飼料添加物)、動物種類別、投与経路別、流通チャネル別 / Veterinary Therapeutics Market (Product: Drug, Vaccines, and Medicated Feed Additives; Animal Type: Companion Animals and Livestock Animals; Route of Administration: Oral, Parenteral, and Others; and Distribution Channel: Veterinary Hospitals & Clinics, Pharmacies & Drug Stores, and Others) - Saudi Arabia Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031 / MRC2205A062資料のイメージです。• レポートコード:MRC2205A062
• 出版社/出版日:Transparency Market Research / 2022年3月17日
• レポート形態:英文、PDF、110ページ
• 納品方法:Eメール
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥764,940 (USD5,795)▷ お問い合わせ
  Multi User¥1,160,940 (USD8,795)▷ お問い合わせ
  Corporate License¥1,556,940 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査レポートは、サウジアラビアの動物用医薬品市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別分析、流通チャネル別分析、投与経路別分析、動物種類別分析、競争状況などの項目を掲載しています。

Saudi Arabia Veterinary Therapeutics Market – Scope of Report
TMR’s report on the veterinary therapeutics market in Saudi Arabia studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the veterinary therapeutics market in Saudi Arabia for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the veterinary therapeutics market in Saudi Arabia from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the veterinary therapeutics market in Saudi Arabia.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the veterinary therapeutics market in Saudi Arabia.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the veterinary therapeutics market in Saudi Arabia. These serve as valuable tools for existing market players as well as for entities interested in participating in the veterinary therapeutics market in Saudi Arabia.

The report delves into the competition landscape of the veterinary therapeutics market in Saudi Arabia. Key players operating in the market in the region have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the veterinary therapeutics market in Saudi Arabia profiled in this report.

Key Questions Answered in Saudi Arabia Veterinary Therapeutics Market Report
What is the sales/revenue generated by veterinary therapeutics across Saudi Arabia during the forecast period?
What are the opportunities in the veterinary therapeutics market in Saudi Arabia?
What are the major drivers, restraints, opportunities, and threats in the market?
Which country market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in Saudi Arabia?

Saudi Arabia Veterinary Therapeutics Market – Research Objectives and Research Approach
The comprehensive report on the veterinary therapeutics market in Saudi Arabia begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the veterinary therapeutics market in Saudi Arabia in terms of product, animal type, route of administration, distribution channel, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the veterinary therapeutics market in Saudi Arabia.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Saudi Arabia Veterinary Therapeutics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Saudi Arabia Veterinary Therapeutics Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Disease Prevalence and Incidence rate
5.2. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Saudi Arabia Veterinary Therapeutics Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Drugs
6.3.1.1. Anti-infective
6.3.1.2. Anti-inflammatory
6.3.1.3. Parasiticides
6.3.1.4. Others
6.3.2. Vaccines
6.3.2.1. Inactivated Vaccines
6.3.2.2. Live Attenuated Vaccines
6.3.2.3. Recombinant Vaccines
6.3.2.4. Others
6.3.3. Medicated Feed Additives
6.3.3.1. Amino Acids
6.3.3.2. Antibiotics
6.3.3.3. Others
6.4. Market Attractiveness Analysis, by Product
7. Saudi Arabia Veterinary Therapeutics Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Distribution Channel, 2017–2031
7.3.1. Veterinary Hospitals & Clinics
7.3.2. Pharmacies & Drug Stores
7.3.3. Others
7.4. Market Attractiveness Analysis, by Distribution Channel
8. Saudi Arabia Veterinary Therapeutics Market Analysis and Forecast, by Route of Administration
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Route of Administration, 2017–2031
8.3.1. Oral
8.3.2. Parenteral
8.3.3. Others
8.4. Market Attractiveness Analysis, by Route of Administration
9. Saudi Arabia Veterinary Therapeutics Market Analysis and Forecast, by Animal Type
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Animal Type, 2017–2031
9.3.1. Companion Animals
9.3.2. Livestock & Others
9.4. Market Attractiveness Analysis, by Animal Type
10. Competition Landscape
10.1. Market Player – Competition Matrix (by tier and size of companies)
10.2. Market Share Analysis, by Company, 2020
10.3. Company Profiles
10.3.1. Boehringer Ingelheim International GmbH
10.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.1.2. Company Financials
10.3.1.3. Growth Strategies
10.3.1.4. SWOT Analysis
10.3.2. Ceva Santé Animale
10.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.2.2. Company Financials
10.3.2.3. Growth Strategies
10.3.2.4. SWOT Analysis
10.3.3. Dechra Pharmaceuticals plc
10.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.3.2. Company Financials
10.3.3.3. Growth Strategies
10.3.3.4. SWOT Analysis
10.3.4. Elanco
10.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.4.2. Company Financials
10.3.4.3. Growth Strategies
10.3.4.4. SWOT Analysis
10.3.5. Al-Takamul Agriculture Co.
10.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.5.2. Company Financials
10.3.5.3. Growth Strategies
10.3.5.4. SWOT Analysis
10.3.6. Virbac
10.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.6.2. Company Financials
10.3.6.3. Growth Strategies
10.3.6.4. SWOT Analysis
10.3.7. Vetoquinol S.A.
10.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.7.2. Company Financials
10.3.7.3. Growth Strategies
10.3.7.4. SWOT Analysis
10.3.8. Zoetis Health
10.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.8.2. Company Financials
10.3.8.3. Growth Strategies
10.3.8.4. SWOT Analysis
10.3.9. Saudi Pharmaceutical Industries (SPI)
10.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.9.2. Company Financials
10.3.9.3. Growth Strategies
10.3.9.4. SWOT Analysis